Tokenized Assets: DeFi’s Biggest Unlock for Markets
DeFi founders argue that tokenized assets are the next growth lever, linking real-world value to on-chain liquidity. ...
Zero Based Budgeting Techniques For Cash Flow
Optimizing your budget with zero-based techniques can significantly improve cash flow. Explore methods that work for you.
23,231 articles
Days, This Cryptocurrency with AI Sparks a $500 Buy Debate
A surge in AI-focused crypto has investors weighing a $500 bet. This article breaks down how the technology works, th...
Swarmer’s 520% Debut Gain Ignites Narrow IPO Spotlight
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
Bank Stocks Just Some Good News for Investors in 2025
A regulatory proposal released March 19 could ease capital buffers for many U.S. banks, freeing up funds for lending,...
Chubb’s 25-Page Shareholder Letter Highlights AI, China
Chubb CEO Evan Greenberg releases a 25-page shareholder letter detailing strategic views on AI, China, and democracy’...
Cowen Raises Strategy Price Target to $395 on BTC Yield
TD Cowen raises its Strategy price target to 395, driven by a shift toward STRC issuance and an improved BTC yield ou...
Wins Have Alphabet Poised to Overtake Tech Giants Soon
Alphabet is tightening the gap with Nvidia as AI wins bolster its diversified business empire. Investors weigh the im...
What Will Actually Happen to Social Security Trust Funds
With the Social Security trust fund edging toward depletion, retirees and workers wonder what will actually happen ne...
Arbor Homes’ Low-$200s Arrival Expands in Louisville Market
Arbor Homes launches its Arrival Series in Louisville, debuting homes from $199,995 to tackle rising housing costs. T...
ChatGPT Claude Models Split on XRP Hitting $3 by Q4
Two AI models clash on XRP's path to $3 by Q4 as regulatory, liquidity, and macro factors shape divergent bets from t...
Humana Just Massive Upgrade Lifts Price Target to $441
Deutsche Bank upgrades Humana to Buy with a near-doubling price target, as analysts anticipate a 2026 rebound in Medi...
Two Distinct Growth Paths: Johnson & Johnson vs AbbVie
Johnson & Johnson and AbbVie report strong Q1 2026 results, showcasing two contrasting growth paths as biosimilar cha...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status